KYNB
Kyntra Bio
KYNB
KYNB
32 hedge funds and large institutions have $7.01M invested in Kyntra Bio in 2026 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
31% less capital invested
Capital invested by funds: $10.2M → $7.01M (-$3.18M)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
Holders
32
Holding in Top 10
–
Calls
$655K
Puts
$7K
Top Buyers
| 1 | +$177K | |
| 2 | +$142K | |
| 3 | +$18K | |
| 4 |
HI
Harbour Investments
Madison,
Wisconsin
|
+$1.56K |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$1.51K |
Top Sellers
| 1 | -$285K | |
| 2 | -$267K | |
| 3 | -$176K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$147K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$113K |
